HIV-associated neurocognitive disorders Neural specificity tire AN cli symptoms. Here we hypothesized that a reduction in neural specificity, or the specificity of neuronal tuning, marker of asymptomatic HAND. To directly test this hypothesis, we applied two ad-on anti ains amajor challenge. arkers of HIV-disease airments in the post
Despite the availability of potent antiretroviral regimens (combination antiretroviral therapy [cART...
ObjectiveWhile HIV-associated neurocognitive disorders (HAND) remain prevalent despite combination a...
Human Immunodeficiency Virus type 1 (HIV-1) infection is a chronic disease that affects ~40 million ...
In the post combination antiretroviral therapy (cART) era, the prevalence of mild forms of HIV-assoc...
AbstractIn the post combination antiretroviral therapy (cART) era, the prevalence of mild forms of H...
Objective: To identify the neural markers of attention dysfunction in patients with HIV-associated n...
HIV-associated neurocognitive disorders (HAND) remain prevalent despite plasma viral suppression by ...
Nearly half of all HIV-positive individuals present with some form of HIV-associated neurocognitive ...
Objective Although milder forms of HIV-associated neurocognitive disorder (HAND) remain prevalent, a...
HIV-associated neurocognitive disorders (HAND) remain prevalent despite plasma viral suppression by ...
ABSTRACT A significant increase in the incidence of cognitive impairment in HIV/AIDS patients has be...
HIV-associated neurocognitive disorders (HANDs) persist even with virologic suppression on combinati...
HIV emerged as a major threat to world health over 30 years ago, and while its effects on the immune...
In 2019, approximately 38 million people were living with human immunodeficiency virus (HIV). Combin...
Human Immunodeficiency Virus (HIV) is known to cause HIV associated neurocognitive disorders (HAND),...
Despite the availability of potent antiretroviral regimens (combination antiretroviral therapy [cART...
ObjectiveWhile HIV-associated neurocognitive disorders (HAND) remain prevalent despite combination a...
Human Immunodeficiency Virus type 1 (HIV-1) infection is a chronic disease that affects ~40 million ...
In the post combination antiretroviral therapy (cART) era, the prevalence of mild forms of HIV-assoc...
AbstractIn the post combination antiretroviral therapy (cART) era, the prevalence of mild forms of H...
Objective: To identify the neural markers of attention dysfunction in patients with HIV-associated n...
HIV-associated neurocognitive disorders (HAND) remain prevalent despite plasma viral suppression by ...
Nearly half of all HIV-positive individuals present with some form of HIV-associated neurocognitive ...
Objective Although milder forms of HIV-associated neurocognitive disorder (HAND) remain prevalent, a...
HIV-associated neurocognitive disorders (HAND) remain prevalent despite plasma viral suppression by ...
ABSTRACT A significant increase in the incidence of cognitive impairment in HIV/AIDS patients has be...
HIV-associated neurocognitive disorders (HANDs) persist even with virologic suppression on combinati...
HIV emerged as a major threat to world health over 30 years ago, and while its effects on the immune...
In 2019, approximately 38 million people were living with human immunodeficiency virus (HIV). Combin...
Human Immunodeficiency Virus (HIV) is known to cause HIV associated neurocognitive disorders (HAND),...
Despite the availability of potent antiretroviral regimens (combination antiretroviral therapy [cART...
ObjectiveWhile HIV-associated neurocognitive disorders (HAND) remain prevalent despite combination a...
Human Immunodeficiency Virus type 1 (HIV-1) infection is a chronic disease that affects ~40 million ...